{"id":4374,"date":"2022-03-29T08:23:16","date_gmt":"2022-03-29T06:23:16","guid":{"rendered":"http:\/\/www.lvsada.lv\/?p=4374"},"modified":"2022-03-29T08:24:55","modified_gmt":"2022-03-29T06:24:55","slug":"29-03-preses-relize","status":"publish","type":"post","link":"https:\/\/www.lvsada.lv\/?p=4374","title":{"rendered":"29.03. Preses rel\u012bze"},"content":{"rendered":"<p style=\"text-align: center;\"><span style=\"font-family: arial, helvetica, sans-serif;\"><strong>Inform\u0101cija pla\u0161sazi\u0146as l\u012bdzek\u013ciem<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\">\u00a0 \u00a0<strong>Latvijas Vesel\u012bbas un soci\u0101l\u0101s apr\u016bpes darbinieku arodbiedr\u012bba (LVSADA<\/strong><strong>) <\/strong><strong>ir inform\u0113jusi Vesel\u012bbas ministriju, ka iebilst pret to, ka atsevi\u0161\u0137u nozaru darbiniekiem tiek saglab\u0101ta pras\u012bba par oblig\u0101tu vakcin\u0113\u0161anos pret Covid-19. \u0160\u0101du l\u0113mumu 15.03.2022. pie\u0146\u0113ma LVSADA valde, \u0146emot v\u0113r\u0101 vair\u0101kus apst\u0101k\u013cus, taj\u0101 skait\u0101 \u2013 zem\u0101k min\u0113tos. <\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\">\u00a0 \u00a0<u>Vispirms<\/u>, Eiropas Padomes Parlament\u0101r\u0101s asamblejas 27.01.2021. rezol\u016bcija Nr. 2361 par Covid-19 vakcin\u0101cijas \u0113tiskajiem, likumiskajiem un praktiskajiem apsv\u0113rumiem nosaka, ka neviens netiek politiski, soci\u0101li vai cit\u0101d\u0101 veid\u0101 ietekm\u0113ts, (piespiests) vakcin\u0113ties, ja pats to nev\u0113las un netiek diskrimin\u0113ts t\u0101p\u0113c, ka nav vakcin\u0113ts vai nev\u0113las vakcin\u0113ties. Eiropas Padomes Parlament\u0101r\u0101s asamblejas darb\u012bbas galvenais m\u0113r\u0137is ir stiprin\u0101t dal\u012bbvalstu parlamentus, veicin\u0101t un aizsarg\u0101t cilv\u0113kties\u012bbas, tiesiskumu un demokr\u0101tisku\u00a0 p\u0101rvald\u012bbu (<a href=\"https:\/\/www.saeima.lv\">https:\/\/www.saeima.lv<\/a>).<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\">\u00a0 \u00a0<u>Otrk\u0101rt<\/u>, s\u0101kot ar 2022. gada janv\u0101ri, Covid-19 izplat\u012bbas intensit\u0101te nevakcin\u0113to cilv\u0113ku vid\u016b b\u016btiski neat\u0161\u0137iras no izplat\u012bbas intensit\u0101tes to cilv\u0113ku vid\u016b, kuri sa\u0146\u0113mu\u0161i pilnu prim\u0101ro vakcin\u0101ciju. Sal\u012bdzinot ar cilv\u0113kiem, kuri sa\u0146\u0113mu\u0161i balstvakcin\u0101ciju, nevakcin\u0113tiem un da\u013c\u0113ji vakcin\u0113tiem cilv\u0113kiem risks infic\u0113ties bija 1,6 reizes augst\u0101ks. Sal\u012bdzinot stacion\u0113to (21. \u2013 27.02.2022.) Covid-19 pacientu strukt\u016bru p\u0113c smaguma un vakcin\u0101cijas statusa, var konstat\u0113t, ka piln\u012bb\u0101 vakcin\u0113ti bija 47%, nevakcin\u0113ti un da\u013c\u0113ji vakcin\u0113ti \u2013 53% pacientu. No vid\u0113ji smag\u0101 st\u0101vokl\u012b eso\u0161ajiem pacientiem 46% bija piln\u012bb\u0101 vakcin\u0113ti, nevakcin\u0113ti un da\u013c\u0113ji vakcin\u0113ti \u2013 54%; no smag\u0101 st\u0101vokl\u012b eso\u0161ajiem pacientiem piln\u012bb\u0101 vakcin\u0113ti bija 48%, nevakcin\u0113ti un da\u013c\u0113ji vakcin\u0113ti \u2013 52%. Kop\u0161 pand\u0113mijas s\u0101kuma Latvij\u0101 miru\u0161i aptuveni 0,7% no slimniekiem, kuriem konstat\u0113ts Covid-19 (<a href=\"https:\/\/www.lsm.lv\">https:\/\/www.lsm.lv<\/a>; <a href=\"https:\/\/www.spkc.gov.lv\">https:\/\/www.spkc.gov.lv<\/a>).<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\">\u00a0 \u00a0<u>Tre\u0161k\u0101rt<\/u>, zin\u0101tnisko p\u0113t\u012bjumu dati liecina, ka p\u0113c Covid-19 p\u0101rslimo\u0161anas (neatkar\u012bgi no smaguma pak\u0101pes), ko apstiprina attiec\u012bgu antivielu kl\u0101tb\u016btne (neatkar\u012bgi no l\u012bme\u0146a), vesel\u012bbas apr\u016bpes darbiniekiem b\u016btiski un ilgsto\u0161i samazin\u0101s atk\u0101rtotas infic\u0113\u0161an\u0101s risks (V. Hall et al., 2021; S. F. Lumley et al., 2021). Patlaban nav pieejami ticami dati par to, vai un kad n\u0101kotn\u0113 b\u016bs atk\u0101rtots b\u016btisks Covid-19 saslimst\u012bbas pieaugums, k\u0101da b\u016bs slim\u012bbas kl\u012bnisk\u0101 gaita un k\u0101da b\u016bs pieejamo vakc\u012bnu efektivit\u0101te pret attiec\u012bgo v\u012brusa paveidu.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\">\u00a0 \u00a0\u00a0<strong>LVSADA ieskat\u0101, <\/strong><strong>darba dev\u0113jam b\u016btu j\u0101pied\u0101v\u0101 darbiniekiem iesp\u0113ju bez maksas vakcin\u0113ties pret infekcijas slim\u012bb\u0101m, ja to pamato epidemiolo\u0123isk\u0101 situ\u0101cija. Jaut\u0101jumu par vakcin\u0101cijas sertifik\u0101ta esam\u012bbas pras\u012bbu darbiniekiem var p\u0101rskat\u012bt, ja k\u013c\u016bst pieejami jauni zin\u0101tniski dati par epidemiolo\u0123isko situ\u0101ciju, k\u0101 ar\u012b vakcin\u0101cijas dro\u0161\u012bbu un efektivit\u0101ti.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\"><strong>\u00a0<\/strong><\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif;\">Inform\u0101ciju sagatavoja LVSADA darba koordin\u0113t\u0101ja Inga Rudz\u012bte (tel. 67847305).<\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif;\">2022. gada 29. mart\u0101<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Inform\u0101cija pla\u0161sazi\u0146as l\u012bdzek\u013ciem \u00a0 \u00a0Latvijas Vesel\u012bbas un soci\u0101l\u0101s apr\u016bpes darbinieku arodbiedr\u012bba (LVSADA) ir inform\u0113jusi Vesel\u012bbas ministriju, ka iebilst pret to, ka atsevi\u0161\u0137u nozaru darbiniekiem tiek saglab\u0101ta pras\u012bba par oblig\u0101tu vakcin\u0113\u0161anos pret Covid-19. \u0160\u0101du l\u0113mumu 15.03.2022. pie\u0146\u0113ma LVSADA valde, \u0146emot v\u0113r\u0101 vair\u0101kus apst\u0101k\u013cus, taj\u0101 skait\u0101 \u2013 zem\u0101k min\u0113tos. \u00a0 \u00a0Vispirms, Eiropas Padomes Parlament\u0101r\u0101s asamblejas 27.01.2021. rezol\u016bcija&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-4374","post","type-post","status-publish","format-standard","hentry","category-4"],"_links":{"self":[{"href":"https:\/\/www.lvsada.lv\/index.php?rest_route=\/wp\/v2\/posts\/4374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lvsada.lv\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lvsada.lv\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lvsada.lv\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lvsada.lv\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4374"}],"version-history":[{"count":4,"href":"https:\/\/www.lvsada.lv\/index.php?rest_route=\/wp\/v2\/posts\/4374\/revisions"}],"predecessor-version":[{"id":4378,"href":"https:\/\/www.lvsada.lv\/index.php?rest_route=\/wp\/v2\/posts\/4374\/revisions\/4378"}],"wp:attachment":[{"href":"https:\/\/www.lvsada.lv\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lvsada.lv\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lvsada.lv\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}